Arrhythmogenic Right Ventricular Dysplasia Genetics
Research findings from Marmara University, Department of Cardiology update understanding of arrhythmogenic right ventricular dysplasia genetics
Published in Cardiovascular Business Week, March 10th, 2009
Current study results from the report, 'Angiotensin-converting enzyme gene polymorphism in arrhythmogenic right ventricular dysplasia: is DD genotype helpful in predicting syncope risk,' have been published. "Arrhythmogenic right ventricular dysplasia (ARVD) is a heritable disorder characterised by fibrofatty replacement of right ventricular myocytes and increased risk of ventricular arrhythmias and sudden cardiac death. Angiotensin-converting enzyme (ACE) gene insertion/deletion (I/D) polymorphism affects myocardial ACE levels," researchers in Istanbul, Turkey report.
"DD genotype favours myocardial fibrosis and is associated with malignant ventricular tachycardia. The...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cardiovascular Business Week
More Articles from Cardiovascular Business Week
- Acorda Therapeutics, Inc.
Acorda Therapeutics Reports Fourth Quarter and Full Year 2008 Financial Results - Amanda Dolan
Amanda Dolan Returns to the Ward-Nasse Gallery With a New Collection of Playful and Uplifting Pieces in Her Aptly Titled 'Heart Attack' Series - American Heart Association
American Heart Association Media Advisory: CDC Says Arthritis Pain May Keep People with Heart Disease Physically Inactive - American Jewish Joint Distribution Committee JDC
American Jewish Joint Distribution Committee JDC Provides Lifeline to More Than 170,000 Elderly Jews in Former Soviet Union - Aneurysm
Endovascular Repair Results in Decrease of Total Aneurysm Deaths - Angioplasty
Immersion Delivers Haptic Medical Simulation for Minimally Invasive Stroke Prevention Procedure - More from this issue of Cardiovascular Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
